Investigation of ultrasound mediated extravasation of a model drug by perfluorobutane nanodroplets
Investigation of ultrasound mediated extravasation of a model drug by perfluorobutane nanodroplets
Objective: perfluorocarbon nanodroplets (NDs) have been widely investigated as both diagnostic and therapeutic agents. There remains, however, a challenge in generating NDs that do not vaporize spontaneously but can be activated at ultrasound pressures that do not produce unwanted bioeffects. In previous work, it has been shown that phospholipid-coated perfluorobutane (PFB) NDs can potentially overcome this challenge. The aim of this study was to investigate whether these NDs can promote drug delivery.
Methods: a combination of high-speed optical imaging and passive cavitation detection was used to study the acoustic properties of the PFB-NDs in a tissue mimicking phantom. PFB-NDs were exposed to ultrasound at frequencies from 0.5 to 1.5 MHz and peak negative pressures from 0.5 to 3.5 MPa. In addition, the penetration depth of two model drugs (Nile Red and 200 nm diameter fluorescent polymer spheres) into the phantom was measured.
Results: PFB NDs were found to be stable in aqueous suspension at both 4°C and 37°C; their size remaining unchanged at 215 ± 11 nm over 24 h. Penetration of both model drugs in the phantom was found to increase with increasing ultrasound peak negative pressure and decreasing frequency and was found to be positively correlated with the energy of acoustic emissions. Extravasation depths >1 mm were observed at 0.5 MHz with pressures <1 MPa.
Conclusion: the results of the study thus suggest that PFB NDs can be used both as drug carriers and as nuclei for cavitation to enhance drug delivery without the need for high intensity ultrasound.
Drug Delivery Systems/methods, Fluorocarbons/chemistry, Nanoparticles, Phantoms, Imaging, Stimuli responsive particles, Acoustic droplet vaporization, Drug delivery, Phase change agents, Cavitation, Ultrasound, Nanodroplets
1573-1584
Wu, Qiang
fad3844e-9eba-496c-876d-3bbc9ee4a689
Choi, Victor
ce368a31-638e-4d1f-b9aa-a0f7d4ea185d
Bau, Luca
7ab4b1fb-e69a-4a53-8275-aceac2c0d264
Carugo, Dario
265c1e1e-90c6-4cbb-b606-5d617ef8e814
Evans, Nicholas D.
33dfbb52-64dd-4c1f-9cd1-074faf2be4b3
Stride, Eleanor
c0143e95-81fa-47c8-b9bc-5b4fc319bba6
2 September 2024
Wu, Qiang
fad3844e-9eba-496c-876d-3bbc9ee4a689
Choi, Victor
ce368a31-638e-4d1f-b9aa-a0f7d4ea185d
Bau, Luca
7ab4b1fb-e69a-4a53-8275-aceac2c0d264
Carugo, Dario
265c1e1e-90c6-4cbb-b606-5d617ef8e814
Evans, Nicholas D.
33dfbb52-64dd-4c1f-9cd1-074faf2be4b3
Stride, Eleanor
c0143e95-81fa-47c8-b9bc-5b4fc319bba6
Wu, Qiang, Choi, Victor, Bau, Luca, Carugo, Dario, Evans, Nicholas D. and Stride, Eleanor
(2024)
Investigation of ultrasound mediated extravasation of a model drug by perfluorobutane nanodroplets.
Ultrasound in Medicine & Biology, 50 (10), .
(doi:10.1016/j.ultrasmedbio.2024.06.016).
Abstract
Objective: perfluorocarbon nanodroplets (NDs) have been widely investigated as both diagnostic and therapeutic agents. There remains, however, a challenge in generating NDs that do not vaporize spontaneously but can be activated at ultrasound pressures that do not produce unwanted bioeffects. In previous work, it has been shown that phospholipid-coated perfluorobutane (PFB) NDs can potentially overcome this challenge. The aim of this study was to investigate whether these NDs can promote drug delivery.
Methods: a combination of high-speed optical imaging and passive cavitation detection was used to study the acoustic properties of the PFB-NDs in a tissue mimicking phantom. PFB-NDs were exposed to ultrasound at frequencies from 0.5 to 1.5 MHz and peak negative pressures from 0.5 to 3.5 MPa. In addition, the penetration depth of two model drugs (Nile Red and 200 nm diameter fluorescent polymer spheres) into the phantom was measured.
Results: PFB NDs were found to be stable in aqueous suspension at both 4°C and 37°C; their size remaining unchanged at 215 ± 11 nm over 24 h. Penetration of both model drugs in the phantom was found to increase with increasing ultrasound peak negative pressure and decreasing frequency and was found to be positively correlated with the energy of acoustic emissions. Extravasation depths >1 mm were observed at 0.5 MHz with pressures <1 MPa.
Conclusion: the results of the study thus suggest that PFB NDs can be used both as drug carriers and as nuclei for cavitation to enhance drug delivery without the need for high intensity ultrasound.
Text
1-s2.0-S030156292400262X-main
- Version of Record
More information
Accepted/In Press date: 29 June 2024
e-pub ahead of print date: 26 July 2024
Published date: 2 September 2024
Keywords:
Drug Delivery Systems/methods, Fluorocarbons/chemistry, Nanoparticles, Phantoms, Imaging, Stimuli responsive particles, Acoustic droplet vaporization, Drug delivery, Phase change agents, Cavitation, Ultrasound, Nanodroplets
Identifiers
Local EPrints ID: 496066
URI: http://eprints.soton.ac.uk/id/eprint/496066
ISSN: 0301-5629
PURE UUID: 5ba7bc32-fc00-400c-85e6-06f382611b68
Catalogue record
Date deposited: 02 Dec 2024 17:48
Last modified: 02 Dec 2024 17:48
Export record
Altmetrics
Contributors
Author:
Qiang Wu
Author:
Victor Choi
Author:
Luca Bau
Author:
Dario Carugo
Author:
Eleanor Stride
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics